ArticlePreventing chronic disease2010
Choropleth map design for cancer incidence, part 2.
Article in Preventing chronic disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Application of Bayesian Regression for the Identification of a Catchment Area for Cancer Cases in Dogs and Cats.Frontiers in veterinary science · 2022Article
- Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.Breast cancer (Tokyo, Japan) · 2021Article
- GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology.Cancer · 2019Review
- Usability Assessment of the Missouri Cancer Registry's Published Interactive Mapping Reports: Round One.JMIR human factors · 2017Article
- Article
- Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba.Canadian respiratory journal · 2017Article
- The emerging role and benefits of boundary analysis in spatio-temporal epidemiology and public health.Spatial and spatio-temporal epidemiology · 2010Article
- Geographic boundary analysis in spatial and spatio-temporal epidemiology: perspective and prospects.Spatial and spatio-temporal epidemiology · 2010Article
- Choropleth map design for cancer incidence, part 1.Preventing chronic disease · 2010Article
- Choropleth map design for cancer incidence, part 2.Preventing chronic disease · 2010Article
- Investigation of Geographical Disparities: The Use of An Interpolation Method For Cancer Registry Data.The Journal of the Oklahoma State Medical AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Choropleth maps are commonly used in cancer reports and community discussions about cancer rates. Cancer registries increasingly use geographic information system techniques. The Centers for Disease Control and Prevention's Division of Cancer Prevention and Control convened a Map Work Group to help guide application of geographic information system mapping techniques and to promote choropleth mapping of data from central cancer registries supported by the National Program of Cancer Registries, especially for comprehensive cancer control planning and evaluation purposes. In this 2-part series, we answer frequently asked questions about choropleth map design to display cancer incidence data. We recommend that future initiatives consider more advanced mapping, spatial analysis, and spatial statistics techniques and include usability testing with representatives of state and local programs and other cancer prevention partners.
Indexed as
Identifiers
20040239PMC2811519What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.